Mirum Pharmaceuticals (MIRM) Cash from Operations (2019 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Cash from Operations of 228763000.0 for Q1 2026, down 11565.63% year-over-year from N/an in Q1 2025, and down 3870.61% quarter-over-quarter from 6067000.0 in Q4 2025.
Powered by 
Analysis
Mirum Pharmaceuticals (MIRM) Cash from Operations (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Cash from Operations history runs 8 years deep, the most recent figure standing at 228763000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 11565.63% year-over-year to 228763000.0; the TTM figure through Mar 2026 stood at 170975000.0 (down 2396.71% YoY), while the FY2025 annual figure was 55827000.0, up 440.7% from the prior year.
- Cash from Operations for Q1 2026 stood at 228763000.0, down from 6067000.0 in the prior quarter.
- The five-year high for Cash from Operations was 39681000.0 in Q3 2025, with the low at 228763000.0 in Q1 2026.
- The 5-year median for Cash from Operations is 16618000.0 (2023), against an average of 20805352.94.
- The sharpest annual moves came in 2025 and 2026: Cash from Operations jumped 896.01% in 2025, then sank 11565.63% in 2026.
- Mirum Pharmaceuticals' Cash from Operations stood at 34270000.0 in 2022, then jumped by 51.51% to 16618000.0 in 2023, then jumped by 69.5% to 5068000.0 in 2024, then jumped by 219.71% to 6067000.0 in 2025, then sank by 3870.61% to 228763000.0 in 2026.
- Business Quant data shows MIRM's Cash from Operations at 228763000.0 in Q1 2026, 6067000.0 in Q4 2025, and 39681000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Mirum Pharmaceuticals | 6.40 Bn | 5.96 Bn | 145.90 Mn | -44.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -44.25 Mn |
| Mar 31, 2026 | -228.76 Mn |
| Dec 31, 2025 | 6.07 Mn |
| Sep 30, 2025 | 39.68 Mn |
| Jun 30, 2025 | 12.04 Mn |
| Mar 31, 2025 | -1.96 Mn |
| Dec 31, 2024 | -5.07 Mn |
| Sep 30, 2024 | 3.98 Mn |
| Jun 30, 2024 | -3.80 Mn |
| Mar 31, 2024 | 15.21 Mn |
| Dec 31, 2023 | -16.62 Mn |
| Sep 30, 2023 | -18.22 Mn |
| Jun 30, 2023 | -17.33 Mn |
| Mar 31, 2023 | -18.77 Mn |
| Dec 31, 2022 | -34.27 Mn |
| Sep 30, 2022 | -26.03 Mn |
| Jun 30, 2022 | -20.17 Mn |
| Mar 31, 2022 | -39.67 Mn |
| Dec 31, 2021 | -33.15 Mn |
| Sep 30, 2021 | -34.20 Mn |